BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27906814)

  • 1. Prevalence and Visual Outcome of Glaucoma With Uveitis in a Thai Population.
    Pathanapitoon K; Smitharuck S; Kunavisarut P; Rothova A
    J Glaucoma; 2017 Mar; 26(3):247-252. PubMed ID: 27906814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Predictors of Poor Visual Outcome in Human Leukocyte Antigen-B27-Associated Uveitis.
    Verhagen FH; Brouwer AH; Kuiper JJ; Ossewaarde-van Norel J; Ten Dam-van Loon NH; de Boer JH
    Am J Ophthalmol; 2016 May; 165():179-87. PubMed ID: 26940162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual Prognosis and Ocular Complications in Herpetic versus HLA-B27- or Ankylosing Spondylitis-associated Anterior Uveitis.
    Hoeksema L; Los LI
    Ocul Immunol Inflamm; 2016 Jun; 24(3):302-12. PubMed ID: 26133756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis.
    Stroh IG; Moradi A; Burkholder BM; Hornbeak DM; Leung TG; Thorne JE
    Ocul Immunol Inflamm; 2017 Aug; 25(4):503-512. PubMed ID: 27003850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical evaluation of uveitis-associated secondary glaucoma.
    Takahashi T; Ohtani S; Miyata K; Miyata N; Shirato S; Mochizuki M
    Jpn J Ophthalmol; 2002; 46(5):556-62. PubMed ID: 12457916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uveitic glaucoma in Behçet's disease: When everything gets complicated].
    Belkhadir K; Boutimzine N; Tachfouti S; Laghmari M; Amazouzi A; Cherkaoui O
    J Fr Ophtalmol; 2020 Sep; 43(7):635-641. PubMed ID: 32622636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime visual disability in open-angle glaucoma and ocular hypertension.
    Forsman E; Kivelä T; Vesti E
    J Glaucoma; 2007 May; 16(3):313-9. PubMed ID: 17438426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis.
    Ma T; Sims JL; Bennett S; Chew S; Niederer RL
    Br J Ophthalmol; 2022 Nov; 106(11):1520-1523. PubMed ID: 34020941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of hemodynamic and immunological parameters in patients with recurrent uveitis complicated by hypertension, Fuchs heterochromic uveitis and Posner-Schlossman syndrome.
    Khramenko NI; Velychko LM; Konovalova NV; Bogdanova OV; Gheorghe LD; Bobescu DV
    Rom J Ophthalmol; 2023; 67(1):20-32. PubMed ID: 37089809
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating the Impact of Uveitis on Visual Field Progression Using Large-Scale Real-World Data.
    Liu X; Kelly SR; Montesano G; Bryan SR; Barry RJ; Keane PA; Denniston AK; Crabb DP
    Am J Ophthalmol; 2019 Nov; 207():144-150. PubMed ID: 31251907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Risk Factors for Developing Glaucoma Among Patients with Uveitis in a University-based Tertiary Referral Center in Riyadh, Saudi Arabia.
    Al Rubaie K; Al Dhahri H; Al Fawaz A; Hemachandran S; Mousa A; Mohamed AG; Al-Obeidan SA; Abu El-Asrar AM
    Ocul Immunol Inflamm; 2016 Oct; 24(5):571-8. PubMed ID: 26470690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for developing glaucoma among patients with uveitis: a nationwide study in Taiwan.
    Hwang DK; Chou YJ; Pu CY; Chou P
    J Glaucoma; 2015 Mar; 24(3):219-24. PubMed ID: 24240883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease.
    Yang P; Wang C; Su G; Pan S; Qin Y; Zhang J; Cao Q; Zhong Z; Zhou C; Wang Y; Kijlstra A
    Br J Ophthalmol; 2021 Dec; 105(12):1678-1682. PubMed ID: 33011689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of uveitic glaucoma in Turkish patients.
    Tekeli O; Elgin U; Takmaz T; Ekşioğlu Ü; Baş Z; Yarangümeli A; Karakurt A; Evren Kemer Ö; Mumcuoğlu T; Aktaş Z; Akman A; Bayer A
    Eur J Ophthalmol; 2021 Jul; 31(4):1836-1843. PubMed ID: 32799547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypopyon in patients with uveitis.
    Zaidi AA; Ying GS; Daniel E; Gangaputra S; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Kempen JH;
    Ophthalmology; 2010 Feb; 117(2):366-72. PubMed ID: 20006905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study.
    Iwao K; Inatani M; Seto T; Takihara Y; Ogata-Iwao M; Okinami S; Tanihara H
    J Glaucoma; 2014 Feb; 23(2):88-94. PubMed ID: 22895522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and aetiology of ocular hypertension in acute and chronic uveitis.
    Kanda T; Shibata M; Taguchi M; Ishikawa S; Harimoto K; Takeuchi M
    Br J Ophthalmol; 2014 Jul; 98(7):932-6. PubMed ID: 24682184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, management and outcome of raised intraocular pressure in childhood-onset uveitis at a tertiary referral centre.
    Tan SZ; Yau K; Steeples LR; Ashworth J; Fenerty C; Jones N
    Br J Ophthalmol; 2019 Jun; 103(6):748-752. PubMed ID: 30021815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of secondary glaucoma in behcet disease.
    Elgin U; Berker N; Batman A
    J Glaucoma; 2004 Dec; 13(6):441-4. PubMed ID: 15534466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urgent Management of Secondary Glaucoma in Uveitis Using the Xen-45 Gel Stent.
    Qureshi A; Jones NP; Au L
    J Glaucoma; 2019 Dec; 28(12):1061-1066. PubMed ID: 31633616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.